Navigation Links
The Prostate Cancer Therapeutics Market 2013-2023
Date:11/12/2013

London (PRWEB) November 12, 2013

Report Details
Prostate cancer therapeutics - assess products, developments, and revenue prospects

How are the leading segments in the prostate cancer therapeutics market performing? Visiongain's new report shows you their prospects to 2023. There you see results, trends, opportunities, and revenue predictions.

Our study lets you assess leading drugs and devices in the prostate cancer therapeutics market, showing their prospects to 2023. There you see financial results, interviews, trends, opportunities, and revenue predictions. You will also find information on pipeline drugs in the market.

Forecasts and other data to help you stay ahead

In our new study you find revenue forecasts of eight leading drugs and five device segments along with an analysis of the overall industry- with historical data, revenue forecasts, growth rates, and market shares. Discover a qualitative analysis too. You also gain 69 figures, 67 tables and an interview with an authority in the industry.

Our work lets you assess the most lucrative parts of the world market for prostate cancer therapeutic products. See now how you can benefit your research, analyses, and decisions there, also saving time.

The following sections highlight what you find in our new investigation.

Prospects for submarkets and products

In addition to analyses of the overall world market, you see revenue forecasting for the main submarkets at world level:
•Prostate cancer drugs
•Prostate cancer devices

See forecasts for prostate cancer drugs

How will drugs perform to 2023 at world level? Our study predicts individual revenues of these products:
•Zytiga
•Lupron
•Zoladex
•Casodex
•Taxotere
•Provenge
•Jevtana
•Xtandi

How will the prostate cancer devices market perform to 2023 at world level
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related medicine news :

1. Weight at time of diagnosis linked to prostate cancer mortality
2. New program makes prostate cancer treatment decisions easier
3. In prostate cancer prognosis, telomere length may matter
4. Unstable chromosomes linked to less favorable response to RT and surgery in prostate cancer patients
5. ASTRO/AUA joint guideline for RT after prostatectomy highlighted at ASTRO Annual Meeting
6. Prostate Cancer Added to List of Diseases Eligible for Zadroga Act Coverage; Parker Waichman LLP Applauds Decision
7. Moffitt Cancer Center launches prostate cancer study focused on black men
8. Made Sick from Prostate Cancer Awareness and Screening
9. LUGPA: Ladies: Save That Special Man in Your Life by Encouraging a Prostate Test in September
10. CEO of Award-Winning SEO Services Company, 180Fusion, Scott Cohen Elected to Emcee 2013 Prostate Cancer Dinner Gala
11. Cleveland Clinic researcher finds genetic mutation in castration-resistant prostate cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2014)... The Business Intelligence Group today announced ... Business program. The BIG Awards specialize in recognizing ... process scored by well-known and experienced leaders and ... this year epitomize what is going right with ... Business Intelligence Group. “The sheer amount of innovation ...
(Date:10/2/2014)... have pinpointed a molecule that may trigger potentially life-threatening ... say this finding could offer a target for new ... Most asthma attacks (80 percent to 90 percent) are ... the British researchers. Most of these are rhinoviruses, which ... The researchers found that a specific molecule called IL-25 ...
(Date:10/2/2014)... Amy Norton HealthDay Reporter ... who have trouble smelling the roses -- literally -- may face ... research suggests. In a study of over 3,000 older Americans, ... rose, orange and peppermint were more than three times as likely ... sharp sense of smell. In fact, anosmia -- the inability ...
(Date:10/1/2014)... protein beta-amyloid is strongly associated with Alzheimer,s disease; however, ... peptide is the causal agent of the onset and ... confirmation is that beta-amyloid is not harmful when found ... when it self-assembles to form the so-called amyloid fibrils ... beta-amyloid alone, but with multiple ones because each aggregate ...
(Date:10/1/2014)... Philadelphia, PA, October 1, 2014 Patients with ... treatment, have a greatly increased risk of depression. ... therapy for chronic hepatitis C virus infection causes ... Omega-3 fatty acids, more commonly known as fish ... including lowering the risk of heart disease and ...
Breaking Medicine News(10 mins):Health News:Innovation Dominant Theme among 2014 Big Awards for Business Winners and Finalists 2Health News:New Clues to How Colds Can Spur Asthma Attacks 2Health News:Could a Fading Sense of Smell Point to Earlier Death? 2Health News:Could a Fading Sense of Smell Point to Earlier Death? 3Health News:Laying siege to beta-amyloid, the key protein in Alzheimer's disease 2Health News:Omega-3 fatty acids may prevent some forms of depression 2
... Online ... clip on teen self esteem as part of its ongoing campaign and mission to affect change ... ... to the number one issue affecting today’s teen girl – low self esteem. It is a ...
... ... Championships Played on SnapSports® Volleyball Surfaces for a second year in a row. ... Pheonix, AZ (PRWEB) ... this year,s Phoenix Volleyball Festival on SnapSports® BounceBack® volleyball surfaces. The tournament is one ...
... ... and Organic Meat Raised Locally, , ... Seattle, WA (PRWEB) July 2, 2010 -- Bill the Butcher Inc. ... said J’Amy Owens, chief executive officer., , ,Located at 3800 34th Ave West in ...
... Allogeneic (donor-derived) stem cell transplant (alloSCT) may be a ... (CLL), regardless of the patient,s underlying genetic abnormalities, according ... in Blood , the journal of the American ... were diagnosed in the United States in 2009 and ...
... the brains of humans and other mammals differed from the ... presumably better). This belief was based, in part, upon the ... the brain responsible for complex cognitive behaviors. A new ... Diego School of Medicine finds that a comparable region in ...
... ... newly expanded pain treatment center in in the Los Angeles area. , ... (PRWEB) July 2, 2010 -- API and the ... Arcadia, California 91007. The Los Angeles area pain management clinic supplements the existing Encino Surgical ...
Cached Medicine News:Health News:Bellaboo Releases One Girl At A Time Documentary 2Health News:Phoenix Volleyball Festival Championships Played on SnapSports Volleyball Surfaces 2Health News:In Time for July 4th Grilling, Bill the Butcher Opens 5th Butcher Shop 2Health News:Patients with treatment-resistant CLL respond positively to stem cell transplants 2Health News:Our brains are more like birds' than we thought 2Health News:Our brains are more like birds' than we thought 3Health News:Advanced Pain Institute Opens Expanded Los Angeles Area Pain Management Center 2
(Date:10/1/2014)... NOTTINGHAM, England , Oct. 1, 2014 ... today announced that its subsidiary, Molecular Profiles Ltd., is ... at the annual CPhI/ICSE Worldwide event in ... companies with the rapid development of both standard and ... screening platform, which incorporates the company,s existing formulation and ...
(Date:10/1/2014)... ANTWERP, Belgium and NEW YORK , ... global Contract Research Organization (CRO) and service provider for the medical ... the opening of offices in New York City ... New York City is strategically centered in one of ... the East Coast", said Philippe Kassab , President at genae ...
(Date:10/1/2014)... Oct. 1, 2014 Trovagene, Inc., (NASDAQ: ... today that Eli Diamond , MD, Assistant ... (MSK), presented clinical data from an ongoing study ... platform for the determination of oncogene mutational status ... The results were presented to both treating physicians ...
Breaking Medicine Technology:Columbia Laboratories' UK Subsidiary To Launch New Development Platform At CPHI 2Columbia Laboratories' UK Subsidiary To Launch New Development Platform At CPHI 3genae Opens Offices in New York City 2Clinical Performance of Trovagene's Precision Cancer Monitoring Platform Presented at Second Annual International ECD Medical Symposium 2Clinical Performance of Trovagene's Precision Cancer Monitoring Platform Presented at Second Annual International ECD Medical Symposium 3Clinical Performance of Trovagene's Precision Cancer Monitoring Platform Presented at Second Annual International ECD Medical Symposium 4
...  Soligenix, Inc. (OTCBB: SNGX) (Soligenix or the Company), ... progress in the development of ThermoVax™, its proprietary ... additional characterization of the stability of prototype vaccines ... excess of three months. These studies are being ...
... Medical, Inc. (OTCBB: AEMD), today released the following ... (Photo: http://photos.prnewswire.com/prnh/20090325/LA88762LOGO-b ) The ... disease targets is to measure changes in patient viral ... is detectable in circulation.  Specific to Hepatitis C virus ...
Cached Medicine Technology:Soligenix Announces Further Progress with ThermoVax™ for Long-Term Vaccine ThermoStability 2Soligenix Announces Further Progress with ThermoVax™ for Long-Term Vaccine ThermoStability 3Soligenix Announces Further Progress with ThermoVax™ for Long-Term Vaccine ThermoStability 4Soligenix Announces Further Progress with ThermoVax™ for Long-Term Vaccine ThermoStability 5Aethlon Medical Note: An Unprecedented Data Point, The Single-Treatment Capture of Hepatitis C Virus (HCV) by the Aethlon Hemopurifier® 2Aethlon Medical Note: An Unprecedented Data Point, The Single-Treatment Capture of Hepatitis C Virus (HCV) by the Aethlon Hemopurifier® 3Aethlon Medical Note: An Unprecedented Data Point, The Single-Treatment Capture of Hepatitis C Virus (HCV) by the Aethlon Hemopurifier® 4
... VISUCAM non-mydriatic fundus camera ... simplicity of fundus imaging. ... to set the standard ... features a unique combination ...
... Afinion HbA1c test and the ... you reliable facts conveniently available ... them. Advising the patient can ... The HbA1c Test Cartridge contains ...
An aid for advancing a pacemaker lead through the subcutaneous tissue of the chest wall to the pacemaker pocket....
The ARK-730A initiates automatic measurement at the optimum measurement point. The ARK-730A maintains fogging throughout multiple measurements, saving total examination time....
Medicine Products: